Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 339K | $36.7M | $108.00 | Feb 28, 2023 | Direct |
ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 62.5K | Feb 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 1 | -$623K | 4 | Mar 2, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 1 | -$867K | 4 | Mar 2, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | EXECUTIVE VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Dec 13, 2021 | 3 | -$15M | 4 | Dec 15, 2021 | EXECUTIVE VICE PRESIDENT |